BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, December 27, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Oct. 12, 2005
View Archived Issues
Alzheimer's Drugs Could Follow New Breakthrough
Read More
Biovitrum Cutting Up To 100 Research Positions
Read More
AIM Wants To Fill Funding Gap For European Biotechs
Read More
Clarification
Read More
Avidex In-Licenses Antigen To Focus On Type I Diabetes
Read More
Other News To Note
Read More
Novexel Begins Phase I Trial, Gathers In Milestone Payment
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)
Read More
New Study Released Touting Global Benefits Of GM Crops
Read More
